DexComTM Receives FDA Approval To Calibrate Its SEVENTM continual Glucose Monitoring System Using Any FDA Cleared Blood Glucose Meter
DexCom, Inc. (NASDAQ:DXCM) announced that it has received Food and Drug Administration (FDA) approval to calibrate the SEVENTM, its seven-day continual glucose monitoring system, using any FDA cleared blood glucose meter. With that approval, patients will be able to calibrate the system without using a connection cable.
Original post by Women’s Health / Gynecology News From Medical News Today
Related Articles
Medtronic Announces FDA Clearance Of New OneTouch(R) Ultralink(TM) Blood Glucose Meter OneTouch® Ping™ Glucose Management System Cleared By FDA OneTouch(R) Ping(TM) Glucose Management System Cleared By FDA FDA Approves Abbott’s FreeStyle Navigator(R) continual Glucose Monitoring System Half The Steps To pop quiz - With The New And Only, All-In-One Blood Glucose Monitoring System
